Tags

Type your tag names separated by a space and hit enter

Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ.
Am J Obstet Gynecol. 1976 Mar 15; 124(6):573-7.AJ

Abstract

Whether use of oral contraceptives is associated with subsequent development of cervical neoplasia is an important public health question. Before evaluating this issue, we must determine if choosing oral contraceptives identifies a woman who is intrinsically at high risk of developing cervical neoplasia. We have examined the demographic and reproductive characteristics as well as cervical premalignant changes manifest by 15- to 44-year-old black women who enrolled in a public family-planning clinic. When compared to IUD acceptors, oral contraceptive acceptors did not have a disproportionately large number of women with traits which predicted for high risk of developing cervical neoplasia. Oral contraceptive acceptors, compared to IUD acceptors, did not have a higher prevalence rate of carcinoma in situ. Oral contraceptive acceptors with no Pap smears prior to initial choice of contraceptive method did have a 1.4-fold higher prevalence rate of cervical dysplasia than IUD acceptors. These results suggest that the deicision to use oral contraceptives, per se, does not identify a group of women at higher risk to develop cervical carcinoma in situ. Such a decision may, however, identify a group with a small increased propensity for developing cervical dysplasia.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

1258912

Citation

Ory, H, et al. "Contraceptive Choice and Prevalence of Cervical Dysplasia and Carcinoma in Situ." American Journal of Obstetrics and Gynecology, vol. 124, no. 6, 1976, pp. 573-7.
Ory H, Naib Z, Conger SB, et al. Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ. Am J Obstet Gynecol. 1976;124(6):573-7.
Ory, H., Naib, Z., Conger, S. B., Hatcher, R. A., & Tyler, C. W. (1976). Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ. American Journal of Obstetrics and Gynecology, 124(6), 573-7.
Ory H, et al. Contraceptive Choice and Prevalence of Cervical Dysplasia and Carcinoma in Situ. Am J Obstet Gynecol. 1976 Mar 15;124(6):573-7. PubMed PMID: 1258912.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Contraceptive choice and prevalence of cervical dysplasia and carcinoma in situ. AU - Ory,H, AU - Naib,Z, AU - Conger,S B, AU - Hatcher,R A, AU - Tyler,C W,Jr PY - 1976/3/25/pubmed PY - 2001/3/28/medline PY - 1976/3/25/entrez KW - Acceptor Characteristics KW - Acceptors KW - Age Factors KW - Cancer KW - Cervical Cancer KW - Contraception KW - Contraceptive Methods KW - Cultural Background KW - Demographic Factors KW - Diseases KW - Education KW - Epidemiologic Methods KW - Ethnic Groups KW - Family Planning KW - Family Planning Programs KW - Fertility KW - Fertility Measurements KW - Iud KW - Marital Status KW - Measurement KW - Neoplasms KW - Nuptiality KW - Oral Contraceptives KW - Parity KW - Population KW - Population Characteristics KW - Population Dynamics KW - Prevalence KW - Research Methodology SP - 573 EP - 7 JF - American journal of obstetrics and gynecology JO - Am J Obstet Gynecol VL - 124 IS - 6 N2 - Whether use of oral contraceptives is associated with subsequent development of cervical neoplasia is an important public health question. Before evaluating this issue, we must determine if choosing oral contraceptives identifies a woman who is intrinsically at high risk of developing cervical neoplasia. We have examined the demographic and reproductive characteristics as well as cervical premalignant changes manifest by 15- to 44-year-old black women who enrolled in a public family-planning clinic. When compared to IUD acceptors, oral contraceptive acceptors did not have a disproportionately large number of women with traits which predicted for high risk of developing cervical neoplasia. Oral contraceptive acceptors, compared to IUD acceptors, did not have a higher prevalence rate of carcinoma in situ. Oral contraceptive acceptors with no Pap smears prior to initial choice of contraceptive method did have a 1.4-fold higher prevalence rate of cervical dysplasia than IUD acceptors. These results suggest that the deicision to use oral contraceptives, per se, does not identify a group of women at higher risk to develop cervical carcinoma in situ. Such a decision may, however, identify a group with a small increased propensity for developing cervical dysplasia. SN - 0002-9378 UR - https://www.unboundmedicine.com/medline/citation/1258912/Contraceptive_choice_and_prevalence_of_cervical_dysplasia_and_carcinoma_in_situ_ L2 - https://linkinghub.elsevier.com/retrieve/pii/0002-9378(76)90057-0 DB - PRIME DP - Unbound Medicine ER -